Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey.

Mariah S WoodNicole HalmerJeanne BertolliLaura B AmsdenJoshua R NugentJin-Mann S LinGretchen RothrockJoelle NadleShua J ChaiJennifer R CopeJamila H ChampsiJames YangElizabeth R UngerJacek Skarbinskinull null

Published in: PloS one (2024)

In a large, integrated health system, 1.67% of adults had ME/CFS-like illness and 14.12% of all persons with ME/CFS-like illness developed it after COVID-19. Though COVID-19 did not substantially increase ME/CFS-like illness in the KPNC population during the study time period, ME/CFS-like illness nevertheless affects a notable portion of this population and is consistent with estimates of ME/CFS prevalence in other populations. Additional attention is needed to improve awareness, diagnosis, and treatment of ME/CFS.

Keyphrases

coronavirus disease
sars cov
risk factors
respiratory syndrome coronavirus
working memory
physical activity
sleep quality
depressive symptoms
case report